<?xml version="1.0" ?>
<document id="33cf03ea72e45ea6d6beeccc91c5145807544728">
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c0" text="molecules Developing Novel G-Quadruplex Ligands: From Interaction with Nucleic Acids to Interfering with Nucleic Acid-Protein Interaction">
    <entity charOffset="0-9" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c0.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="71-84" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c0.e1" ontology_id="CHEBI_33696" text="Nucleic Acids" type="chemical"/>
    <entity charOffset="79-84" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c0.e2" ontology_id="CHEBI_37527" text="Acids" type="chemical"/>
  </chunk>
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1" text="G-quadruplex is a special secondary structure of nucleic acids in guanine-rich sequences of genome. G-quadruplexes have been proved to be involved in the regulation of replication, DNA damage repair, and transcription and translation of oncogenes or other cancer-related genes. Therefore, targeting G-quadruplexes has become a novel promising anti-tumor strategy. Different kinds of small molecules targeting the G-quadruplexes have been designed, synthesized, and identified as potential anti-tumor agents, including molecules directly bind to the G-quadruplex and molecules interfering with the binding between the G-quadruplex structures and related binding proteins. This review will explore the feasibility of G-quadruplex ligands acting as anti-tumor drugs, from basis to application. Meanwhile, since helicase is the most well-defined G-quadruplex-related protein, the most extensive research on the relationship between helicase and G-quadruplexes, and its meaning in drug design, is emphasized. Molecules 2019, 24, 396 2 of 29">
    <entity charOffset="49-62" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e0" ontology_id="CHEBI_33696" text="nucleic acids" type="chemical"/>
    <entity charOffset="57-62" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e1" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="181-184" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e2" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="389-398" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e3" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="518-527" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e4" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="566-575" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e5" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="661-669" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e6" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="728-735" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e7" ontology_id="CHEBI_52214" text="ligands" type="chemical"/>
    <entity charOffset="976-980" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e8" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <entity charOffset="1004-1013" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c1.e9" ontology_id="CHEBI_25367" text="Molecules" type="chemical"/>
  </chunk>
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2" text="The search for and further optimization of compounds targeting the G-quadruplexes may lead to compounds of increasing specificity and drug potential [13,14]. However, compared to developing inhibitors for a specific enzyme or protein, selective interaction with the G-quadruplex structures in particular genome regions is difficult to achieve. An alternative strategy for discovering novel G-quadruplex-related compounds is to interfere with the binding between G-quadruplex-forming sequences and the binding proteins [15][16][17]. Considering the fact that the shifts between various secondary structures in nucleic acids actually are regulated by several proteins binding to the nucleic acids [18][19][20][21], this alternative strategy seems attractive. Therefore, we will further discuss the proteins that interact with G-quadruplexes, including both stabilizing and dissociating proteins, based on emerging findings regarding this kind of binding proteins.">
    <entity charOffset="134-138" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e0" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <entity charOffset="190-200" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e1" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="509-517" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e2" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="609-622" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e3" ontology_id="CHEBI_33696" text="nucleic acids" type="chemical"/>
    <entity charOffset="617-622" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e4" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="657-665" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e5" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="681-694" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e6" ontology_id="CHEBI_33696" text="nucleic acids" type="chemical"/>
    <entity charOffset="689-694" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e7" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="796-804" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e8" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="884-892" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e9" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="952-960" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c2.e10" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
  </chunk>
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3" text="In addition, the helicases are a class of molecular motor proteins that unwind DNAs or RNAs using the energy produced by the hydrolysis of nucleotide triphosphates (NTP) [22]. Helicases play essential roles in nucleic acid metabolism by facilitating cellular processes including replication, recombination, DNA repair, and transcription [23][24][25]. Furthermore, several members of the helicase family have the ability to regulate the degradation of G-quadruplexes, and subsequently regulate related biological processes to achieve anti-cancer effects [26][27][28][29][30][31][32]. Small molecules with influence on the function of G-quadruplexes via helicase have been discovered, developed, and well-evaluated [33,34]. Therefore, we hope to focus on the progress made in helicase-related leading compounds to give a comprehensive view of this field.">
    <entity charOffset="58-66" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e0" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="139-149" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e1" ontology_id="CHEBI_36976" text="nucleotide" type="chemical"/>
    <entity charOffset="165-168" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e2" ontology_id="CHEBI_17326" text="NTP" type="chemical"/>
    <entity charOffset="210-222" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e3" ontology_id="CHEBI_33696" text="nucleic acid" type="chemical"/>
    <entity charOffset="218-222" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e4" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="307-310" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e5" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="589-598" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c3.e6" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
  </chunk>
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c4" text="A G-tetrad structure in guanylic acid, according to X-ray diffraction data, was first reported by Gellert et al. in 1962 [35]. Twenty years later, studies showed that the G-quadruplex structure can form in G-rich repeats at the ends of telomeres [36]. By immunostaining the telomeric G-quadruplexes using a specific antibody, G-quadruplex structures were proven in 2001 to be formed in cells [37]. From then on, several G-quadruplex-specific single-chain antibodies (scFv antibody) have been developed using different display processes, and these scFv antibodies have been used in DNA or RNA G-quadruplex mapping in cells [38][39][40]. Combined with next-generation sequencing, genome mapping and thorough functional elucidation have been reported [3] . All these results support the existence of G-quadruplex structures in the genome.">
    <entity charOffset="581-584" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c4.e0" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="588-591" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c4.e1" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
  </chunk>
  <chunk id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5" text="The G-quadruplex structure is a stacked secondary structure that can form in a specific repetitive sequence of G-rich DNA or RNA. The core structures in the G-quadruplex are two or three G-quartets, which form from four guanines via Hoogsteen hydrogen bonds. In addition, the G-quadruplex is stabilized by univalent metal cations (Na + or K + ) located in the central channel of the plane (Figure 1 ). G-quadruplex structures may form intramolecular G-quadruplexes within a single DNA strand, or intermolecular G-quadruplexes between multiple DNA strands [41]. Moreover, due to the various orientations of nucleic acids strands during folding, the G-quadruplex structures can further divide into different conformations, including parallel, antiparallel, and hybrid conformations ( Figure 2) . Generally, the configuration and stability of the G-quadruplex structures are related to the length and the composition of the G-quadruplex-forming sequence, the length of the annulus structure between Gs, the number of DNA strands, and the type of binding cations [42][43][44][45].">
    <entity charOffset="118-121" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e0" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="243-251" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e1" ontology_id="CHEBI_18276" text="hydrogen" type="chemical"/>
    <entity charOffset="243-251" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e2" ontology_id="CHEBI_49637" text="hydrogen" type="chemical"/>
    <entity charOffset="316-329" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e3" ontology_id="CHEBI_25213" text="metal cations" type="chemical"/>
    <entity charOffset="322-329" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e4" ontology_id="CHEBI_36916" text="cations" type="chemical"/>
    <entity charOffset="481-484" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e5" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="543-546" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e6" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="606-619" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e7" ontology_id="CHEBI_33696" text="nucleic acids" type="chemical"/>
    <entity charOffset="614-619" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e8" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="1014-1017" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e9" ontology_id="CHEBI_16991" text="DNA" type="chemical"/>
    <entity charOffset="1051-1058" id="33cf03ea72e45ea6d6beeccc91c5145807544728.c5.e10" ontology_id="CHEBI_36916" text="cations" type="chemical"/>
  </chunk>
</document>
